A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer

Update Il y a 4 ans
Reference: NCT00371254

Woman Man

Extract

This study will determine whether the investigational drug dasatinib is effective in treatment of women with progressive advanced triple-negative breast cancer.


Inclusion criteria

  • Breast Cancer ,Metastasis


Links